ES439017A1 - Un procedimiento para la preparacion de nuevas piridinas. - Google Patents

Un procedimiento para la preparacion de nuevas piridinas.

Info

Publication number
ES439017A1
ES439017A1 ES439017A ES439017A ES439017A1 ES 439017 A1 ES439017 A1 ES 439017A1 ES 439017 A ES439017 A ES 439017A ES 439017 A ES439017 A ES 439017A ES 439017 A1 ES439017 A1 ES 439017A1
Authority
ES
Spain
Prior art keywords
pyrimidines
compounds
formula
compound
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES439017A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH APPLIC S SOC GEN DE
Original Assignee
RECH APPLIC S SOC GEN DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH APPLIC S SOC GEN DE filed Critical RECH APPLIC S SOC GEN DE
Publication of ES439017A1 publication Critical patent/ES439017A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES439017A 1975-04-10 1975-06-30 Un procedimiento para la preparacion de nuevas piridinas. Expired ES439017A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7511154A FR2306697A1 (fr) 1975-04-10 1975-04-10 Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants

Publications (1)

Publication Number Publication Date
ES439017A1 true ES439017A1 (es) 1977-06-16

Family

ID=9153719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES439017A Expired ES439017A1 (es) 1975-04-10 1975-06-30 Un procedimiento para la preparacion de nuevas piridinas.

Country Status (12)

Country Link
US (1) US3984411A (enExample)
JP (1) JPS51118777A (enExample)
BE (1) BE829845A (enExample)
CA (1) CA1036597A (enExample)
CH (1) CH603626A5 (enExample)
DE (1) DE2528360A1 (enExample)
ES (1) ES439017A1 (enExample)
FR (1) FR2306697A1 (enExample)
GB (1) GB1502182A (enExample)
IT (1) IT1036400B (enExample)
LU (1) LU72743A1 (enExample)
NL (1) NL7507441A (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176972B (hu) * 1977-06-13 1981-06-28 Gyogyszerkutato Intezet Sposob poluchenija novykh proizvodnykh piridazinil-gidrazona
US4648896A (en) * 1982-11-15 1987-03-10 Ciba-Geigy Corporation 2-aryl-4,6-dihalopyrimidines as antidote for protecting cultivated plants from phytotoxic damage caused by herbicides
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
ATE247104T1 (de) * 1997-11-05 2003-08-15 Neurosearch As Azaring-ether-derivate und ihre verwendung als nicotinic-ach-rezeptormodulatoren
ATE374766T1 (de) 2003-01-14 2007-10-15 Arena Pharm Inc 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
JP2006518763A (ja) * 2003-02-24 2006-08-17 アリーナ ファーマシューティカルズ， インコーポレイテッド グルコース代謝のモジュレーターとしてのフェニル−およびピリジルピペリジン誘導体
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
CA2441775C (en) * 2003-09-23 2004-09-28 Westport Research Inc. Container for holding a cryogenic fluid
WO2005121121A2 (en) * 2004-06-04 2005-12-22 Arena Pharmaceuticals, Inc. Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
DK1931654T3 (da) * 2005-09-16 2009-07-27 Arena Pharm Inc Stofskiftemodulatorer og behandling af lidelser relateret dertil
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
JP5657383B2 (ja) 2007-08-30 2015-01-21 ダウ アグロサイエンシィズ エルエルシー ２−（置換フェニル）−６−アミノ−５−アルコキシ、チオアルコキシ、およびアミノアルキル−４−ピリミジンカルボキシラート、ならびに除草剤としてのそれらの使用
JP5856980B2 (ja) 2010-01-27 2016-02-10 アリーナ ファーマシューティカルズ， インコーポレイテッド （Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス
CN103221410B (zh) 2010-09-22 2017-09-15 艾尼纳制药公司 Gpr119受体调节剂和对与其相关的障碍的治疗
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US10934244B2 (en) 2015-06-15 2021-03-02 Nmd Pharma A/S Compounds for use in treating neuromuscular disorders
PT3310760T (pt) 2015-06-22 2022-11-10 Arena Pharm Inc Sal cristalino de l-arginina de ácido (r)-2-(7-(4-ciclopentil-3-(trifluorometil)benziloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para utilização em distúrbios associados a recetores de s1p1
MA47504A (fr) 2017-02-16 2019-12-25 Arena Pharm Inc Composés et méthodes de traitement de l'angiocholite biliaire primitive
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US12440477B2 (en) 2017-12-14 2025-10-14 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
AU2019280822A1 (en) 2018-06-06 2021-01-07 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259623A (en) * 1963-06-14 1966-07-05 Olin Mathieson Process for preparing 2-(secondary amino)-halogenopyrimidines
US3261833A (en) * 1964-10-20 1966-07-19 Smith Kline French Lab 2,4-diamino-6-aminoalkoxy pyrimidines
GB1143167A (en) * 1967-01-25 1969-02-19 Ucb Sa Derivatives of pyrimidine

Also Published As

Publication number Publication date
IT1036400B (it) 1979-10-30
CA1036597A (fr) 1978-08-15
FR2306697B1 (enExample) 1979-08-10
CH603626A5 (enExample) 1978-08-31
BE829845A (fr) 1975-12-04
US3984411A (en) 1976-10-05
DE2528360A1 (de) 1976-10-21
NL7507441A (nl) 1976-10-12
JPS51118777A (en) 1976-10-18
LU72743A1 (enExample) 1975-10-08
FR2306697A1 (fr) 1976-11-05
GB1502182A (en) 1978-02-22

Similar Documents

Publication Publication Date Title
ES439017A1 (es) Un procedimiento para la preparacion de nuevas piridinas.
IE41724L (en) Diphenylsulphoxide derivatives
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
ES477265A1 (es) Procedimiento para la preparacion de fosfato y sales de me- tronidazol.
ES454709A1 (es) Un procedimiento para la preparacion de n-fosfonometil-gli- cina.
MX168599B (es) Procedimiento para la preparacion de compuestos cefemicos
UA6016A1 (uk) Спосіб одержання 4-епідауноміціна
UA7228A1 (uk) Спосіб одержання похідних n-(4-індолілпіперідиноалкіл )бензімідазолону або їх солей з кислотами
CH614448A5 (en) Process for the preparation of novel tertiary amines and their acid addition salts, and compounds thus prepared
ES418924A1 (es) Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas.
HUT38623A (en) Process for production of derivatives of n-substituated neuramin-acid
FR2445318A1 (fr) Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines
FR2406640A1 (fr) Production de 2,6-diaminonebularines
FR2355834A1 (fr) Procede de preparation des 1-phenyl-3-amino pyrazoles
GR1002384B (el) Μεθοδος παρασκευης παραγωγων υποκατεστημενου στυρολιου.
ES373764A1 (es) Procedimiento para la obtencion de n-fluor-acetil-amino-me-til-ureas.
JPS55157562A (en) Novel intermediate useful for production of antitumor compounds
GR79558B (enExample)
ES436902A1 (es) Procedimiento para la obtencion de hidrocloruro de carniti- na.
FR2398738A1 (fr) Preparation de benzoylurees
JPS5262299A (en) Production of novel riphamycin compound
ES462843A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos.
ES423484A1 (es) Procedimiento para la obtencion de derivados de estilbeno que contienen grupos sulfo.
ES404463A1 (es) Procedimiento para la produccion de 6-hidroxi-dihidro-ura- cilos.
JPS51143668A (en) Production of novel 22 imidazoline compound

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202